Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avelumab in Advanced Hepatocellular Carcinoma After Prior Sorafenib
NCT03389126Phase 2Completed
- Sponsor
- Seoul National University Hospital
- Start
- Dec 2017
- Primary completion
- Dec 2019
- Modality
- Immune Checkpoint Inhibitors, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of avelumab in hepatocellular carcinoma (HCC), sponsored by Seoul National University Hospital. Started Dec 2017; status: completed.
02
Drugs
avelumab
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT03389126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03389126.